285 related articles for article (PubMed ID: 11707639)
1. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
[TBL] [Abstract][Full Text] [Related]
2. Antibodies made against a formaldehyde-protein adduct cross react with an acetaldehyde-protein adduct. Implications for the origin of antibodies in human serum which recognize acetaldehyde-protein adducts.
Pietrzak ER; Shanley BC; Kroon PA
Alcohol Alcohol; 1995 May; 30(3):373-8. PubMed ID: 7545992
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
[TBL] [Abstract][Full Text] [Related]
4. Acetaldehyde adducts and autoantibodies against VLDL and LDL in alcoholics.
Wehr H; Rodo M; Lieber CS; Baraona E
J Lipid Res; 1993 Jul; 34(7):1237-44. PubMed ID: 8371070
[TBL] [Abstract][Full Text] [Related]
5. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration.
Tuma DJ; Thiele GM; Xu D; Klassen LW; Sorrell MF
Hepatology; 1996 Apr; 23(4):872-80. PubMed ID: 8666344
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin-acetaldehyde adducts in human alcohol abusers.
Niemelä O; Israel Y
Lab Invest; 1992 Aug; 67(2):246-52. PubMed ID: 1380106
[TBL] [Abstract][Full Text] [Related]
7. [Immune response against protein epitopes modified with acetaldehyde and its clinical significance in alcoholic liver diseases].
Yokoyama H
Arukoru Kenkyuto Yakubutsu Ison; 1993 Dec; 28(6):483-96. PubMed ID: 7510476
[TBL] [Abstract][Full Text] [Related]
8. Ethanol-derived immunoreactive species formed by free radical mechanisms.
Moncada C; Torres V; Varghese G; Albano E; Israel Y
Mol Pharmacol; 1994 Oct; 46(4):786-91. PubMed ID: 7969061
[TBL] [Abstract][Full Text] [Related]
9. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a.
Veneskoski M; Turunen SP; Kummu O; Nissinen A; Rannikko S; Levonen AL; Hörkkö S
Free Radic Biol Med; 2011 Aug; 51(4):834-43. PubMed ID: 21683785
[TBL] [Abstract][Full Text] [Related]
10. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
Viitala K; Israel Y; Blake JE; Niemelä O
Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers.
Viitala K; Makkonen K; Israel Y; Lehtimäki T; Jaakkola O; Koivula T; Blake JE; Niemelä O
Alcohol Clin Exp Res; 2000 Jul; 24(7):1103-9. PubMed ID: 10924016
[TBL] [Abstract][Full Text] [Related]
12. Acetaldehyde-modified hemoglobin as a marker of alcohol consumption: comparison of two new methods.
Sillanaukee P; Seppa K; Koivula T; Israel Y; Niemela O
J Lab Clin Med; 1992 Jul; 120(1):42-7. PubMed ID: 1613327
[TBL] [Abstract][Full Text] [Related]
13. IgA immune responses against acetaldehyde adducts and biomarkers of alcohol consumption in patients with IgA glomerulonephritis.
Kaartinen K; Niemelä O; Syrjänen J; Alatalo P; Pörsti I; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
Alcohol Clin Exp Res; 2009 Jul; 33(7):1231-7. PubMed ID: 19389190
[TBL] [Abstract][Full Text] [Related]
14. Studies on the usefulness of acetaldehyde-modified proteins and associated antibodies as markers of alcohol abuse.
Worrall S; Jersey JD; Wilce PA; Seppa K; Sillanaukee P
Alcohol Alcohol Suppl; 1994; 2():503-7. PubMed ID: 8974375
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption.
Niemelä O; Juvonen T; Parkkila S
J Clin Invest; 1991 Apr; 87(4):1367-74. PubMed ID: 1707062
[TBL] [Abstract][Full Text] [Related]
16. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
Hietala J; Koivisto H; Latvala J; Anttila P; Niemelä O
Alcohol Clin Exp Res; 2006 Oct; 30(10):1693-8. PubMed ID: 17010136
[TBL] [Abstract][Full Text] [Related]
17. Protein adduct species in muscle and liver of rats following acute ethanol administration.
Patel VB; Worrall S; Emery PW; Preedy VR
Alcohol Alcohol; 2005; 40(6):485-93. PubMed ID: 16131499
[TBL] [Abstract][Full Text] [Related]
18. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay.
Xu D; Thiele GM; Kearley ML; Haugen MD; Klassen LW; Sorrell MF; Tuma DJ
Chem Res Toxicol; 1997 Sep; 10(9):978-86. PubMed ID: 9305579
[TBL] [Abstract][Full Text] [Related]
19. Conversion of acetaldehyde-protein adduct epitopes from a nonreduced to a reduced phenotype by antigen processing cells.
Klassen LW; Jones BL; Sorrell MF; Tuma DJ; Thiele GM
Alcohol Clin Exp Res; 1999 Apr; 23(4):657-63. PubMed ID: 10235301
[TBL] [Abstract][Full Text] [Related]
20. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant.
Thiele GM; Tuma DJ; Willis MS; Miller JA; McDonald TL; Sorrell MF; Klassen LW
Alcohol Clin Exp Res; 1998 Nov; 22(8):1731-9. PubMed ID: 9835288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
